Inventera KRX:0007J0KOSDAQ

인벤테라 · Korean news coverage and regulatory filings, organized.

Articles, 24h1
Articles, 7 days1
DART filings, 7 days1
Articles tracked40since Sep 11

In Q3 2026, Inventera reported revenue of ₩0m and an operating loss of ₩2.7bn. Inventera (인벤테라) appeared in 1 Korean news article and 1 DART filing over the past seven days. Coverage peaked on Nov 6 with 9 articles. The most common catalyst was tech & capacity (1). It was most often mentioned alongside LG Chem.

Filing signals Insider buying Clinical trial filing 4 quarters of losses Screener

Inventera at a glance from DART filings

Results trend
Operating loss in each of the last 4 quarters; Q3 2026 operating loss of ₩2.7bn a loss again after the previous quarter.
Ownership changes
2 5%-holder and insider ownership reports in the past 120 days (1 increases, 1 decreases).

Figures the company filed on DART, grouped by ATS View. Not a buy or sell call; see the cards below and the DART originals.

Inventera today: up or down?

No sign-up, one tap a day. These numbers show what visitors think and are not investment advice.

Upcoming dates as filed

  • Mar 31 Annual report filing deadlinein 134 days · period ending Dec 2026

Dates Inventera stated in its DART filings. A conversion period opening does not mean new shares appear that day; bondholders must request conversion.

Inventera quarterly results separate, KRW

QuarterRevenueYoYOperating profitNet income
Q3 2026₩0m–−₩2.7bn−₩2.5bn
Q2 2026₩0m–−₩2.5bn−₩2.3bn
Q3 2025₩0m–−₩2.8bn−₩2.6bn
Q2 2025₩0m–−₩1.6bn−₩1.4bn

Inventera ranks #2043 of 2,345 Korean listed companies by Q3 2026 operating profit. Q3 2026 Korean earnings rankings →

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Inventera top stories 2 weeks, by number of outlets

  1. 1
    Inventerra signs contract with LG Chem to produce pancreaticobiliary MRI contrast raw material
    6 outlets · 7 articlesFirst report Nov 6 09:46 메디파나뉴스LG Chem
  2. 2
    Invenrta partners with LG Chem on consignment production of three MRI contrast agents
    1 outlets · 1 articlesFirst report Nov 6 11:10 PRESS9PartnershipLG Chem
  3. 3
  4. 4

Latest Inventera news Korean headlines